RecruitingNot ApplicableNCT05216666

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Abductor Insufficiency After Total Hip Arthroplasty; Risk Factors and Diagnosis


Sponsor

Sahlgrenska University Hospital

Enrollment

580 participants

Start Date

May 11, 2022

Study Type

INTERVENTIONAL

Summary

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Inclusion Criteria2

  • Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty.
  • Ability to understand and write swedish.

Exclusion Criteria4

  • Impaired funktion of the contralateral hip or knees causing limping.
  • Neuromuscular diseases
  • Postoperative leg length discrepancy excceding 1 cm
  • Postoperative discrepancy in femoral offset exceeding 25% of the femoral offset of the contralateral hip.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELateral approach

Total hip arthroplasty performed through a lateral surgical approach (Gammer)

PROCEDUREPosterior approach

Total hip arthroplasty performed through a posterior surgical approach (Moore)


Locations(1)

Sahlgrenska University Hospital

Mölndal, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05216666